Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company. The U.S. Food and ...

Apria Healthcare and Byram Healthcare, both part of the Owens & Minor family, have entered into a new national provider ...

Abstract: Obstructive sleep apnea (OSA) in children is a prevalent and serious respiratory condition linked to cardiovascular morbidity. Polysomnography, the standard diagnostic approach, faces ...

Roughly 39 million Americans suffer from a condition that can mean major health problems down the line — but many have no idea they’ve got it. Despite the soaring numbers, experts say 85% to 90% don’t ...

MUSKEGON, Mich. — About 30 million people in the United States deal with sleep apnea. Of those, only about 6 million are even diagnosed. Disruptive sleep can affect mental clarity, put a strain on ...

Call it the war on the snore. Startups are developing new options for obstructive sleep-apnea patients who can’t tolerate continuous positive airway pressure, or CPAP, the gold-standard therapy.

The SONA scoring system demonstrated superior performance compared with existing obstructive sleep apnea screening tools. The SONA scoring system is an easy-to-administer and effective screening tool ...

A centuries-old tradition may soon find a place in modern medicine. Researchers have discovered that a simple breathing exercise involving a conch shell can ease symptoms of a common sleep disorder.

GLP-1 receptor agonists (GLP-1RA) are emerging as a potential therapeutic option for patients with obstructive sleep apnea (OSA), according to a recent review that examined growing clinical evidence.

For those suffering from obstructive sleep apnea (OSA), the condition could be significantly worse on the weekends. After investigating changes in severity, researchers at Flinders University in ...

Please provide your email address to receive an email when new articles are posted on . An OSA-related heart rate response greater than 9.4 bpm or hypoxic burden greater than 87.1% minutes/hour ...